Industry News
Biotechnology Industry News
ESMO: Novartis links prostate cancer drug to improved pain, quality of life as regulatory filings near
ESMO: Novartis links prostate cancer drug to improved pain, quality of life as regulatory filings near ntaylor Thu, 09/16/2021 - 11:23
ESMO: Zymeworks lays down marker in fight to unseat Herceptin
ESMO: Zymeworks lays down marker in fight to unseat Herceptin ntaylor Thu, 09/16/2021 - 08:28
Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it
Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it badams Thu, 09/16/2021 - 04:44
How do faulty genes drive cancer? There’s a surprising immune connection, study finds
How do faulty genes drive cancer? There's a surprising immune connection, study finds arlene.weintraub Wed, 09/15/2021 - 15:12
Newly discovered immune cells block melanoma metastasis in mice and could inspire new treatments
Newly discovered immune cells block melanoma metastasis in mice and could inspire new treatments arlene.weintraub Wed, 09/15/2021 - 09:58
Abingworth, Gimv and Pfizer back stealthy Swiss startup’s $61M round to crack gene therapy delivery
Abingworth, Gimv and Pfizer back stealthy Swiss startup's $61M round to crack gene therapy delivery ntaylor Wed, 09/15/2021 - 09:17
Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub
Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub badams Wed, 09/15/2021 - 08:27
Theravance axing 75% of staff, slashing R&D budget after flunking phase 3
Theravance axing 75% of staff, slashing R&D budget after flunking phase 3 ntaylor Wed, 09/15/2021 - 08:01
Moderna, AbCellera join forces to tackle major mRNA opportunity
Moderna, AbCellera join forces to tackle major mRNA opportunity ntaylor Wed, 09/15/2021 - 01:28
Sanofi dumps Principia Biopharma’s San Francisco labs with plans to immediately cut 38 jobs
Sanofi dumps Principia Biopharma's San Francisco labs with plans to immediately cut 38 jobs nhigginsdunn Tue, 09/14/2021 - 11:36
After 3 big exits, Lightstone snags largest fund yet with $375M geared toward next biotechs, medtechs
After 3 big exits, Lightstone snags largest fund yet with $375M geared toward next biotechs, medtechs klahucik Tue, 09/14/2021 - 08:40
RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients
RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients badams Tue, 09/14/2021 - 08:38
UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout
UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout ntaylor Tue, 09/14/2021 - 07:54
Another death blights Astellas’ $3B Audentes buy as FDA slaps clinical hold on the test
Another death blights Astellas' $3B Audentes buy as FDA slaps clinical hold on the test badams Tue, 09/14/2021 - 03:37
Kapeller’s Rome bags $77M to strike gold in the backwaters of the genome
Kapeller's Rome bags $77M to strike gold in the backwaters of the genome ntaylor Mon, 09/13/2021 - 11:40
Provention will wait for FDA to ‘opine’ on new data after teplizumab rejection, eyes Q4 for further talks
Provention will wait for FDA to 'opine' on new data after teplizumab rejection, eyes Q4 for further talks badams Mon, 09/13/2021 - 09:37
Attacking Alzheimer’s by blocking ‘frustrated’ amyloid proteins before they form plaques
Attacking Alzheimer's by blocking 'frustrated' amyloid proteins before they form plaques arlene.weintraub Mon, 09/13/2021 - 09:18
4 years after leaving Prime time, Rusty Williams lands a new job leading school of Walking Fish
4 years after leaving Prime time, Rusty Williams lands a new job leading school of Walking Fish badams Mon, 09/13/2021 - 09:04
AbbVie bets $370M on pivotal eye disease gene therapy, puts up $1.4B in biobucks
AbbVie bets $370M on pivotal eye disease gene therapy, puts up $1.4B in biobucks ntaylor Mon, 09/13/2021 - 08:26
Everest bags COVID-19 program in bid to conquer Chinese mRNA market
Everest bags COVID-19 program in bid to conquer Chinese mRNA market ntaylor Mon, 09/13/2021 - 05:21